Please login to the form below
reimbursement
This page shows the latest reimbursement news and features for those working in and with pharma, biotech and healthcare.
Brexit contributes to surge in generic drug prices
The letter also describes the state of the current pricing and reimbursement systems, which are operated by the Department of Health and Social Care (DHSC).
Latest news
-
Beneluxa: the future of European market access?
The pharmaceutical companies know every detail about their product and the reimbursement system in each country, while at the same time two countries in Europe often wouldn’t know anything about ... One prerequisite for a shift towards an
-
Better together when buying medicines? Taking stock of the BeNeLuxA initiative
On information sharing there is the Pharmaceutical Pricing and Reimbursement Information (PPRI) network, although it is wider than just Europe. ... There is MEDEV too, an informal cooperation on the assessment, pricing and reimbursement of medicines in
-
CAR-Ts take centre stage as ASH18 comes to a close
what some commentators think is a reason (alongside price and reimbursement) for sluggish uptake of first-generation CAR-Ts.
-
MPs threaten to publish Vertex’s Orkambi price if no deal struck
Vertex has been attempting to gain reimbursement for its combination treatment Orkambi since 2016, but saw the drug rejected by cost effectiveness watchdog NICE that year.
-
Symkevi approval in Europe helps Vertex expand CF treatment
Vertex has been in an ugly standoff with budget holder NHS England over pricing and reimbursement of Orkambi, with a stalemate meaning most patients in the country still can’t access
More from news
Approximately 38 fully matching, plus 448 partially matching documents found.
Latest Intelligence
-
Digital applications are transforming the market access landscape
They can anticipate payer requirements, prioritise resources, plan evidence generation, get a head start on HTA and reimbursement submissions, and provide a useful institutional memory.
-
Pharma: in search of the sustainable ‘win win’ with the NHS
reimbursement deals.
-
Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe
Pricing &Reimbursement. After setting its sights on reaching the market for 16 years, Alnylam wants to get off on the right foot with payers.
-
Tackling a formidable foe
All will be fighting for reimbursement across a squeezed financial landscape so good trial data alone may not be a clear route to authorisation.
-
China: AstraZeneca’s new engine for growth and innovation
The central government has also updated its national reimbursement drug list (NRDL) to include more and more innovative treatments, although this list remains restricted and is not regularly updated. ... This means the out-of-pocket cost for healthcare
More from intelligence
Approximately 12 fully matching, plus 126 partially matching documents found.
Latest appointments
-
Ipsen hires general manager, Laura Hamill joins Gilead and Orchard expands leadership team
There he oversaw the oncology-focused company's launch in the region, as well as the launch and UK reimbursement of its PARP inhibitor in recurrent ovarian cancer. ... During her 16-year stint with Amgen, Hamill worked in a number of executive roles,
-
Weekly industry appointments
Brian Jamieson, chairman, Mesoblast, said: “Swedish’s strong understanding of US healthcare resource allocation and reimbursement metrics is in line with the board’s objective to strengthen its commercial focus.”.
-
Claes Buxfeldt joins NDA
He becomes its new HTA director. AstraZeneca’s former global price and reimbursement director Claes Buxfeldt has joined the NDA advisory board.
-
Mereo BioPharma appoints head of patient access and commercial planning
In this role, Hughes-Wilson was responsible for Sobi’s commercialisation approach and led pricing, reimbursement and access teams for the group’s rare disease product portfolio.
-
W2O bolsters its commercialisation offering
with pricing and reimbursement strategy and communications.
More from appointments
Approximately 0 fully matching, plus 20 partially matching documents found.
Latest from PMHub
-
Peadar Coyle announced as Business Development Director for Ashfield Ireland
We see a number of challenges in the Irish market from restructures in mainstream pharma to delays in reimbursement of new medicines.
-
Solaris Health looks at the gene therapy revolution
burden of gaining reimbursement was a major hurdle for potential prescribers.
-
PRMA Consulting Ltd
PRMA Consulting is an independent consultancy solving some of the most challenging pricing, reimbursement and market access issues facing international pharmaceutical and biotechnology companies today. ... Global reimbursement Director, top-20
-
Mastering the precision medicine opportunity
However, outside the US is a different story, where the reimbursement landscape for testing is heterogeneous and internal pathology capabilities are often preferred. ... Market reimbursement is driving the industry towards value-based care, which rewards
-
Value Genome LLC
Assisting mid to late stage clinical development prepare for their first commercialization specializing in market access strategies, medical affairs, health economics, pricing and reimbursement.
More from PMHub
Approximately 0 fully matching, plus 49 partially matching documents found.
Featured jobs
-
Experienced Medical Writers
-
Competitive Salary and Benefits
- Account Executive/ Senior Account Executive
-
competitive Salary Offfered
- CALLING ALL SENIOR HEALTHCARE PR FREELANCERS!!!!! ACCOUNT DIRECT...
-
EXCELLENT DAY RATES AVAILABLE
-
Senior Account Manager
-
Competitive Salary Offered
-
Associate Director
-
£75, 000-90, 000
-
Medical Writer
-
Salary TBC
- Manager - Immunology, Therapeutic Area Communications & Publ...
-
Competitive Salary Offered
-
Associate Medical Director
-
Excellent PTO, bonus and 401k package
-
Account Director
-
Competitive Salary Offered
-
Business Director
-
Competitive Salary Offered
-
Medical Writer
-
Bonus Scheme, PTO &Private Healthcare
- Account Manager / Senior Account Manager
-
35, 000-40, 000
-
Systematic Reviewer - Oxford
-
Negotiable
- Business Development Director – Health Education
-
excellent commission
- Senior Account Executive with progression to Account Manager, Me...
-
Excellent package
-
Account Manager / Account Director
-
Competative
Subscribe to our email news alerts
PMHub
Porterhouse Medical Group
The Porterhouse Medical Group provides market research, insights, and scientific and medical communication services to the pharmaceutical industry across the...
Latest intelligence
- AstraZeneca’s oncology renaissance
- Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
- Navigating the antibiotic resistance crisis
- Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
- Combined immunotherapies – potential and pitfalls
- ‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...
Quick links
Infographics
